Relocation of the
European Medicines Agency

Dublin

Where the world comes to work
ARROW

The Irish Government believes that relocation of the European Medicines Agency to Dublin will lead to the best outcomes for the Agency, its staff, stakeholders and, most importantly, the citizens of Europe. There are many reasons why Dublin is the ideal location for the EMA. Dublin can provide a sustainable and smooth transition for the EMA and for the European regulatory network and all other stakeholders.


Find out more about the bid by watching the video below or downloading the bid document (PDF format, large file)

Download brochure Download bid document

read the latest news and media

1

Seamless transition

A key factor in the successful relocation of the EMA will be a seamless transition of operations to its new location.

Read more

2

Excellent quality of life

The suitability of Dublin as a location for young professionals and their families will be hugely important in ensuring retention of staff.

Read more

3

A great place to live

Information on what its like to live, work and learn in Dublin

Read more

4

World-class talent pool

Dublin offers an exceptional, highly educated and internationally diverse young talent pool with fluency across all European languages.

Read more

5

Dynamic life sciences sector

Ireland has a long tradition of pharmaceutical operations excellence, with nine of the top ten global pharmaceutical companies located here.

Read more

6

News and Media

Latest information and press releases.

Read more

Press Release - Minister for Health Simon Harris says Dublin is the perfect new home for the European Medicines Agency

01/08/2017

Ireland submits its bid to relocate the European Medicines Agency from London to Dublin

Minister for Health Simon Harris has said that Dublin is the perfect new home for the European Medicines Agency. Ireland has now submitted its formal bid to relocate the EMA from London to Dublin. The UK’s decision to leave the EU means that the Agency will have to move as a result of Brexit.

Read more

Minister Catherine Byrne attends EPSCO Informal Meeting of EU Health Ministers in Tallinn

21/07/2017

Minister of State for Health Promotion and the National Drugs Strategy, Catherine Byrne today (21st July) attended an informal meeting of EU Health Ministers where she also had one to one meetings with representatives from the UK, Finland, Croatia, Latvia and the Czech Republic.

Read more